What did @julianajfigueroa actually say?
Honestly, it's nearly impossible to tell. The transcript is garbled beyond any reasonable interpretation, reading as something like "I just am I will up to daddy everything is well city depending." That's not a paraphrase problem, that's the actual auto-generated text. What we can work with is the caption: the creator tagged "MOTS" and "GLOW PEPTIDE" alongside a syringe emoji, shot at what appears to be @BeautySculptSpa. That framing, peptides administered at a med spa with a focus on aesthetics, is where this fact-check has to live.
The visual context matters here. The hashtags point to two distinct compounds: MOTS-c, a mitochondria-derived peptide with metabolic research behind it, and some version of a "glow peptide," which is colloquial language likely referring to GHK-Cu (copper peptide) or a similar skin-focused compound. Neither of these is FDA-approved for the uses implied.
Does the science back this up?
For MOTS-c, there's real but early-stage research. For a generic "glow peptide," the evidence ranges from moderately promising to marketing-driven noise, depending on which compound is actually being used.
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, first characterized by Lee et al. (2015, Cell Metabolism). That original paper showed MOTS-c improved insulin sensitivity and reduced obesity in mice on high-fat diets. Subsequent work by Reynolds et al. (2021, Nature Communications) found MOTS-c levels decline with age in humans and that exogenous administration improved physical performance in older male mice. Impressive rodent data. Human clinical trials are limited to very small studies, and no large randomized controlled trial has confirmed these effects in humans.
GHK-Cu, the most likely candidate for "glow peptide," has better cosmetic data. Pickart and Margolina (2018, Cosmetics) reviewed decades of research showing GHK-Cu stimulates collagen synthesis, has antioxidant properties, and may support wound healing in vitro and in animal models. Subcutaneous injection of GHK-Cu is a different question from topical application, and that specific route lacks robust human safety data at the doses used in med spa settings.
What did they get wrong (or right)?
Credit where it's due: MOTS-c is a real compound with legitimate scientific interest, and GHK-Cu has more peer-reviewed support than most peptides promoted on TikTok. Choosing these two over, say, random "fat-burning" peptide blends shows at least some curation.
The problems start with context. Neither compound is approved by the FDA for injection in healthy adults seeking aesthetic or longevity benefits. Presenting an injection at a commercial spa as casually as a skincare routine glosses over real regulatory and safety gaps. The syringe emoji aesthetic normalizes IV or subcutaneous peptide use in a setting where most viewers have no way to evaluate the actual product quality, dosing, or compounding source.
Compounded peptides, which is what these almost certainly are, are not subject to the same manufacturing standards as FDA-approved drugs. The FDA has specifically flagged certain peptides, including BPC-157 and TB-500, for removal from compounding pharmacies. The regulatory status of MOTS-c for compounding is actively unsettled. That's not a technicality. It's a real safety consideration the video ignores entirely.
What should you actually know?
If you're considering MOTS-c or a copper peptide injection after watching a 30-second TikTok, pump the brakes and read past the hashtags.
MOTS-c research is genuinely interesting, but the human data is thin. A 2022 pilot study (Kim et al., Aging) showed some metabolic markers improved in a small cohort, but "small cohort" means you should hold conclusions loosely. Longevity researchers are watching this space, not prescribing it broadly.
GHK-Cu injected subcutaneously is not the same as GHK-Cu in a serum. Topical data does not transfer to injectable safety profiles automatically. Ask any compounding pharmacist about sterility testing, and then ask the spa if their supplier provides that documentation.
The "glow" framing is also worth scrutinizing. Collagen synthesis effects observed in lab settings do not automatically translate to visible skin changes in healthy adults. Marketing language like "glow" is not a clinical endpoint. No study has measured "glow" as an outcome because it's not a measurable clinical endpoint.
If a provider is recommending these compounds, they should be explaining the research limitations, the compounding source, and what monitoring looks like. A TikTok caption is not informed consent.